Alexander Adam, Ph.D.
Shareholder Principal
Alexander Adam is a highly experienced patent attorney and former scientist who advises clients on protecting and commercializing cutting-edge technologies across medical devices, biotechnology, life sciences, computer systems, electronics, imaging software, control systems, mechanical devices, telecommunications, and clean energy.
Alex focuses his practice on drafting and prosecuting complex patent applications and developing strategic intellectual property portfolios aligned with clients’ business objectives. He also has experience in trademark opposition and cancellation proceedings, patent litigation, due diligence, and preparing invalidity and non-infringement opinions. For more than a decade, Alex has represented major research universities, emerging growth companies, and established small and medium-sized businesses, earning a reputation for translating sophisticated technologies into durable, enforceable, and commercially meaningful IP assets.
Alex’s work and client service have been recognized by leading legal directories and peer-reviewed publications, including, The Best Lawyers in America, Super Lawyers, and LMG Life Sciences, reflecting consistent recognition over the past two years for excellence in patent prosecution and IP strategy.
His patent experience spans a wide range of advanced technologies, including semiconductor manufacturing; laboratory devices for the pharmaceutical industry; 3-D modeling and imaging software for surgical planning; computer-controlled prosthetic devices; automatic speech recognition systems; needle-free injection technologies; fuel cells; drug infusion pumps; wearable and implantable sensors; fiber optics and photonic sensors; augmented reality systems; microfluidics and diagnostics; medical implants; and nanomaterials. Alex also regularly advises on artificial intelligence–enabled technologies, including neural networks, machine learning, natural language processing, and Internet of Things (IoT) platforms.
In addition, Alex counsels clients on open source software compliance, open source patent issues, and corporate policies governing the use of open source software—an increasingly critical area for software-driven, AI-enabled, and regulated products.
Alex leverages his technical background and legal experience to advise clients on high-value strategic matters, including IP portfolio evaluation for investors, patentability and freedom-to-operate analyses, non-infringement and invalidity opinions, portfolio management, licensing and collaboration agreements, competitive IP intelligence, and merger and acquisition due diligence.
Alex is an active contributor to the innovation ecosystem. He is a member of the Medical Development Group of Boston (MDG) and the German-American Business Council of Boston (GABC), where he has served on the Board of Directors since 2021 and as Secretary since 2023. He is a frequent speaker and event co-organizer and has recently presented on 3D Printing for Medical Innovations, Patenting Strategies for Entrepreneurs, Artificial Intelligence in Medicine, Software as a Medical Device (SaMD), Optics and Photonics in Healthcare, and Strategies for Medical Device Startups.